← Leaderboards
Andrew Dunham
New Health Sciences, Inc.
$1,484,879
Attributed
$2,969,757
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $997.7K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$2,969,757 · 1
By mechanism
R44$2,969,757 · 1
Top collaborators
- Tatsuro Yoshida3 shared
Most similar at New Health Sciences, Inc.
Same institution · by research overlap
- Tatsuro Yoshida$6,067,826
- Biree Andemariam$339,077
- Laurel Omert$339,077
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignDiffusionCostAdoptionDevicesAuthorization DocumentationBaseAdverse EventBiochemistryAmericanAdverse EffectsBiomechanicsBloodBlood BanksBlood TransfusionBlood VesselsCell InjuryBiochemicalClinical DataClinical ResearchCommercializationComparative StudyContractsDose
Grant awards (3)
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$980,623
R44 · FY2018 · HL
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$997,658
R44 · FY2017 · HL
Regulatory Approval & Commercialization of an RBC Processing and Storage System to Improve Transfusion Therapy by Minimizing Oxidative Damage to RBC during Storage$991,476
R44 · FY2016 · HL